Oral fluoroquinolones for maintenance treatment of melioidosis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 5, 1997, Pages 599-601

  Chaowagul, W ^a   Suputtamongkul, Y ^b   Smith, M D ^c   White, N J ^b,c  

^a Sappasitthiprasong Hospital   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Burkholderia pseudomallei; Chemotherapy; Fluoroquinolones; Melioidosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; ORAL DRUG ADMINISTRATION; TREATMENT FAILURE;

BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI;

EID: 0030664849     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90044-4     Document Type: Article

References (13)

1. Chaowagul, W., White, N. J., Dance, D. A. B., Wattanagoon, Y., Naigowit, P., Davis, T. M. E., Looareesuwan, S. & Pitakwatchara, N. (1989). Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. Journal of Infectious Diseases, 159, 890-899.
2. Chaowagul, W., Suputtamongkol, Y., Dance, D. A. B., Rajchanuvong, A., Pattaraarechachai, J. & White, N. J. (1993). Relapse in melioidosis: incidence and risk factors. Journal of Infectious Diseases, 168, 1181-1185.
3. Dance, D. A. B., Wuthiekanun, V., Chaowagul, W. & White, N. J. (1989a). The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. Journal of Antimicrobial Chemotherapy, 24, 295-309.
4. Dance, D. A. B., Wuthiekanun, V., Naigowit, P. & White, N. J. (1989b). Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. Journal of Clinical Pathology, 42, 645-648.
5. Leelarasamee, A. & Bovornkitti, S. (1989). Melioidosis: review and update. Reviews of Infectious Disease, 11, 413-425.
6. Lumbiganon, P. & Sookpranee, T. (1992). Ciprofloxacin therapy for localized melioidosis. Pediatric Infectious Diseases, 11, 418-419.
7. McEniry, D. W., Gillespie, S. H. & Felmingham, D. (1989). Susceptibility of Pseudomonas pseudomallei to new betalactam and aminoglycoside antibiotics. Journal of Antimicrobial Chemotherapy, 21, 171-175.
8. Pruksachartvuthi, S., Aswapokee, N. & Thakerngpol, K. (1990). Survival of Pseudomonas pseudomallei inside human phagocytes. Journal of Medical Microbiology, 31, 109-114.
9. Rajchanuvong, A., Chaowagul, W., Suputtamongkol, Y., Smith, M. D., Dance, D. A. B. & White, N. J. (1995). A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 546-549.
10. Smith, M. D., Wuthiekanun, V., Walsh, A. L. & White, N. J. (1994). Susceptibility of Pseudomonas pseudomallei to some newer β-lactam antibiotics and antibiotic combinations using time-kill studies. Pseudomonas pseudomallei. Journal of Antimicrobial Chemotherapy, 33, 145-149.
11. Suputtamongkol, Y., Dance, D. A. B., Chaowagul, W., Wattanagoon, Y., Wuthiekanun, V. & White, N. J. (1991). Amoxycillin-clavulanic acid treatment of melioidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 672-675.
12. Suputtamongkol, Y., Rajchanuvong, A., Chaowagul, W., Dance, D. A. B., Smith, M. D., Wuthiekanun, V., Walsh, A. L., Pukrittayakamee, S. & White, N. J. (1994). Ceftazidime versus coamoxiclav in the treatment of severe melioidosis. Clinical Infectious Diseases, 19, 846-853.
13. Walsh, A. L., Smith, M. D., Wuthiekanun, V. & White, N. J. (1995). Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment. Antimicrobial Agents and Chemotherapy, 39, 2356-2358.